Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Niacin, N-3 fatty acids and insulin resistance.

Trial Profile

Niacin, N-3 fatty acids and insulin resistance.

Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Niacin (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 27 Jan 2011 Status changed from recruiting to completed.
    • 22 Apr 2008 The expected completion date for this trial is now 1 Dec 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top